Cyclopropylamine inactivation of cytochromes P450: Role of metabolic intermediate complexes

被引:36
作者
Cerny, MA [1 ]
Hanzlik, RP [1 ]
机构
[1] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA
关键词
cytochrome p450; flavin-containing monooxygenase; metabolic intermediate complex; mechanism-based inactivation; suicide substrate;
D O I
10.1016/j.abb.2005.02.020
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The inactivation of cytochrome P450 enzymes by cyclopropylamines has been attributed to a mechanism involving initial one-electron oxidation at nitrogen followed by scission of the cyclopropane ring leading to covalent modification of the enzyme. Herein, we report that in liver microsomes N-cyclopropylbenzylamine (1) and related compounds inactivate P450 to a large extent via formation of metabolic intermediate complexes (MICs) in which a nitroso metabolite coordinates tightly to the heme iron, thereby preventing turnover. MIC formation from 1 does not occur in reconstituted P450 systems with CYP2B1/2, 2C11 or 2E1, or in microsomes exposed to gentle heating to inactivate the flavin-containing monooxygenase (FMO). In contrast, N-hydroxy-N-cyclopropylbenzylamine (3) and N-benzylhydroxylamine (4) generate MICs much faster than I in both reconstituted and microsomal systems. MIC formation from nitrone 5 (PhCH = N(O)cPr) is somewhat faster than from 1, but very much faster than the hydrolysis of 5 to a primary hydroxylamine. Thus the major overall route from 1 to a P450 MIC complex would appear to involve FMO oxidation to 3, further oxidation by P450 and/or FMO to nitrone 5 ' (C2H4C = N(O)CH2Ph), hydrolysis to 4, and P450 oxidation to alpha-nitrosotoluene as the precursor to oxime 2 and the major MIC from 1. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:265 / 275
页数:11
相关论文
共 59 条
[1]   PARTICIPATION OF CYTOCHROME-P-450 ISOZYMES IN N-DEMETHYLATION, N-HYDROXYLATION AND AROMATIC HYDROXYLATION OF METHAMPHETAMINE [J].
BABA, T ;
YAMADA, H ;
OGURI, K ;
YOSHIMURA, H .
XENOBIOTICA, 1988, 18 (05) :475-484
[2]  
BONDON A, 1989, J BIOL CHEM, V264, P1988
[3]  
BUENING MK, 1974, DRUG METAB DISPOS, V2, P386
[4]   MICROSOMAL OXIDATION OF THIOBENZAMIDE - A PHOTOMETRIC ASSAY FOR THE FLAVIN-CONTAINING MONO-OXYGENASE [J].
CASHMAN, JR ;
HANZLIK, RP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 98 (01) :147-153
[5]   OXIDATION OF N-HYDROXYNORZIMELDINE TO A STABLE NITRONE BY HEPATIC MONOOXYGENASES [J].
CASHMAN, JR ;
YANG, ZC ;
HOGBERG, T .
CHEMICAL RESEARCH IN TOXICOLOGY, 1990, 3 (05) :428-432
[6]  
Cerny MA, 2003, DRUG METAB REV, V35, P98
[7]   A versatile new preparation of cyclopropylamines from acid dialkylamides [J].
Chaplinski, V ;
deMeijere, A .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1996, 35 (04) :413-414
[8]   HYDROGENOLYSE .1. UBER DIE KATALYTISCHE DEBENZYLIERUNG VON SEKUNDAREN AMINEN [J].
DAHN, H ;
SOLMS, U .
HELVETICA CHIMICA ACTA, 1952, 35 (04) :1162-1168
[9]   Kinetic isotope effects implicate the iron-oxene as the sole oxidant in P450-catalyzed N-dealkylation [J].
Dowers, TS ;
Rock, DA ;
Rock, DA ;
Jones, JP .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (29) :8868-8869
[10]   INHIBITION OF MIXED-FUNCTION OXIDATIONS BY SUBSTRATES FORMING REDUCED CYTOCHROME-P-450 METABOLIC-INTERMEDIATE COMPLEXES [J].
FRANKLIN, MR .
PHARMACOLOGY & THERAPEUTICS PART A-CHEMOTHERAPY TOXICOLOGY AND METABOLIC INHIBITORS, 1977, 2 (01) :227-245